PPD appoints Colin Hill to its Board of Directors

Pharmaceutical Product Development, LLC asserts Colin Hill, an acclaimed name in the health care technology and a connoisseur in precision medicine to its board of directors. He is presently the chairman, CEO and co-founder of GNS Healthcare, a significant precision medicine company.

Chairman and chief executive officer of PPD, David Simons declared that bringing Colin Hill on board will ensure immense industry level experience. He says, “He is an excellent addition to our board because, like PPD, he has a keen focus on using technological innovations, real-world evidence and patient-centric solutions to improve patient health.”

Colin Hill co-founded GNS Healthcare way back in 2000 out of Cornell University having pursued a bachelor’s degree in physics from Virginia Tech, as well as master’s degrees in physics from both McGill University and Cornell University. GNS vows to incorporate the advanced innovations in machine learning, computing and mathematics to expedite biomedical and health care data yielding cures that alleviate the load of human disease. Hill also serves on the board of mobile health information company Biotelemetry Inc along with serving as the founding board member of Tmed, a non-profit foundation committed to the acceleration of personalised medicine. In addition to all the esteemed posts that he has diligently served for years, he is also a voracious speaker at national and international, scientific and industrial conferences ,having appeared in various media platforms like the Wall Street Journal, CNBC’s Morning Call to name a few proves him to be a multi- faceted professional.

Image Source: PPD